secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0000950170-23-023627
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology annual meeting: directors elected, say-on-pay and auditor ratified
--------------------------------------------------------------------------------

- Stockholders elected Robert More, Janet Napolitano, Vicki Sato, and Elliott Sigal as Class I directors; each received over 98M votes for.
- Advisory vote on executive compensation approved: 106.0M for, 4.4M against, 97K abstentions, 8.3M broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 118.7M for, 41.7K against, 109.8K abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/0000950170-23-023627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/vir-20230519.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-023627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer